
Written in response to Michael Specter’s article, “Seeds of Doubt: An Activist’s Controversial Crusade against Genetically Modified Crops” in The New Yorker (August 25, 2014). The activist whose work he criticizes is renowned Indian scientist and ecofeminist Vandana Shiva. This is Part One of two.
In Michael Specter’s article in The New Yorker, “Seeds of Doubt: An Activist’s Controversial Crusade against Genetically Modified Crops,” the author was remiss in omitting overarching narratives in the global food conversation, as well as vital details to clarify the agricultural and ethical landscape in which food scholar-activist Vandana Shiva works. In his celebration of genetic innovation, Specter ignores sciences, such as agroecology, that criticize and co-exist with biotechnology. Most appallingly, Specter repeats a slanderous remark against Shiva without challenging its accuracy. While I appreciate Specter’s attempt to weigh both sides of an issue, as a non-profit director seeking food security for peasants, Shiva cannot be compared with deep-pocketed agribusinesses, which must first attend to a financial bottom line before meeting any humanitarian goals that may be quite honest, despite the smell of greenwashing.
Specter’s article is dubiously well-timed to belittle the hard work of anti-GMO (Genetically Modified Organisms) activists and policymakers in Vermont who face legal challenges to a GMO labeling law passed in April 2014. State-level GMO labeling has become an important political issue in the U.S., as other states prepare ballot measures and similar legislation. Consumers in the E.U., Australia, China, New Zealand, Russia, South Korea, and the U.K. have already either banned or required labeling of genetically modified foods. Just like the so-called “debate” over climate change, the conversation on food safety continues with a hefty dose of political maneuvering. Continue reading “Demagogues, Scientists, or Saints: Michael Specter’s Neglected Territory in the Global Food Landscape of Vandana Shiva and the Biotech Industry by Sarah E. Robinson”








